drugset / Trial / NCT04427917
Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese Participants
RandomizedParallel-groupDouble-blindBasic science
Summary
This is a Phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of multiple oral doses of PF-06835919 in healthy adult Japanese participants. A total of approximately 8 healthy participants will be enrolled in this study. Participants will be randomized to 2 groups to receive PF-06835919 or placebo treatment with a randomization ratio of 3:1.
Timeline
- Start
- 2020-11-24
- Primary completion
- 2021-03-31
- Completion
- 2021-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-06835919 | Small molecule | 300 mg | Oral |
Indications
No indication recorded.